This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jansen, T. L. Articles by Thien, T. Search for Related Content PubMed PubMed Citation Articles by Jansen, T. L. Articles by Thien, T.

Hypertension, Vol 18, 640-647, Copyright © 1991 by American Heart Association

ARTICLES

Attenuated forearm vasodilator response to atrial natriuretic factor in the elderly

TL Jansen, P Smits, AC Tan and T Thien
Department of Medicine, University Hospital Nijmegen, St. Radboud, University of Nijmegen, The Netherlands.

The vasodilator potency of human atrial natriuretic factor-(99-126) was investigated in the forearm vascular bed of 10 young and 10 elderly normotensive volunteers with venous occlusion strain gauge plethysmography. Atrial natriuretic factor was infused at six increasing dose steps into the brachial artery from 0.001 up to 0.3 microgram/min/100 ml of forearm volume. This induced a mean +/- SEM increase in blood flow from 1.4 +/- 0.2 up to 6.0 +/- 1.0 ml/min/100 ml in the young and from 1.4 +/- 0.2 up to 3.9 +/- 0.6 ml/min/100 ml in the elderly. The dose-response curves of forearm blood flow and of forearm vascular resistance after increasing infusion rates of atrial natriuretic factor were shifted to the right in the elderly when compared with the young subjects. The mean percent decrease in forearm vascular resistance, induced by atrial natriuretic factor, during this dose-response curve averaged -31 +/- 3% in the elderly versus -56 +/- 3% in the young subjects (p = 0.0002). The calculated forearm spillover of the second messenger of atrial natriuretic factor, cyclic guanosine monophosphate, significantly increased from baseline values of 1.2 +/- 1.1 and 0.7 +/- 0.5 pmol/min/100 ml in young and elderly subjects, respectively, up to 23.2 +/- 5.0 and 30.5 +/- 7.0 pmol/min/100 ml during the highest dose of atrial natriuretic factor (both p less than 0.01 versus baseline). There were no significant differences in the increments of the forearm spillover of this second messenger between both age groups.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A. J.H.M Houben, M. M.E Krekels, N. C Schaper, M. J.M.J Fuss-Lejeune, S. A Rodriguez, and P. W de Leeuw Microvascular effects of atrial natriuretic peptide (ANP) in man: studies during high and low salt diet Cardiovasc Res, August 1, 1998; 39(2): 442 - 450. [Abstract] [Full Text] [PDF]

				M. Kawamura, T. Adachi, J. Nakajima, T. Fujiwara, and K. Hiramori Factors That Affect Calorie-Sensitive and Calorie-Insensitive Reduction in Blood Pressure During Short-term Calorie Restriction in Overweight Hypertensive Women Hypertension, March 1, 1996; 27(3): 408 - 413. [Abstract] [Full Text]